An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Study Overview
=================
Brief Summary
-----------------
A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Detailed Description
-----------------
A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Official Title
-----------------
An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Conditions
-----------------
Coronary Artery Disease

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Informed Consent > 25 years Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms. Acute Coronary Syndrom Exclusion Criteria: -

Ages Eligible for Study
-----------------
Minimum Age: 25 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluation of patients with Acute Coronary Syndromes. | Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome. | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Estimation of the percentage of patients. | Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina. | Baseline | 
| Description of the methods of patients' evacuation. | Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS. | Baseline | 
| Estimation of the interval until the arrival in the hospital. | Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations. | Baseline | 
| Evaluation of the blood test analysis during hospitalization. | Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization. | Baseline | 
| Description of the administered medication. | Description of the pharmaceutical treatment administered during hospitalization and monitoring period. | Baseline - 6 months | 
| Evaluation of the male patients with erectile dysfunction. | Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome. | Baseline - 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
CAD, STEMI, non STEMI, Unstable angina, Greece